Skip to main content

Type2diabetes clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for
  • Type 2 Diabetes and Blood Brain Barrier Improvement

    Sorry, not yet accepting patients

    The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.

    Los Angeles, California

Our lead scientists for Type2diabetes research studies include .

Last updated: